USD 101.02
(0.02%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 248.92 Million USD | 0.29% |
2022 | 231 Million USD | 13.29% |
2021 | 203.91 Million USD | 12.21% |
2020 | 181.73 Million USD | 25.78% |
2019 | 144.48 Million USD | 26.81% |
2018 | 113.93 Million USD | 24.08% |
2017 | 91.82 Million USD | 1.06% |
2016 | 90.86 Million USD | 20.67% |
2015 | 75.29 Million USD | 14.67% |
2014 | 65.66 Million USD | 25.61% |
2013 | 52.27 Million USD | 6.95% |
2012 | 48.88 Million USD | -30.18% |
2011 | 70.01 Million USD | 3.13% |
2010 | 67.88 Million USD | 4.7% |
2009 | 64.83 Million USD | 11.4% |
2008 | 58.2 Million USD | 15.8% |
2007 | 50.26 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q3 | 69.65 Million USD | 4.21% |
2024 Q1 | 64.53 Million USD | 7.08% |
2024 Q2 | 63.57 Million USD | -1.48% |
2023 Q3 | 63.89 Million USD | 5.12% |
2023 Q2 | 60.77 Million USD | 1.63% |
2023 Q4 | 60.26 Million USD | -5.67% |
2023 Q1 | 59.8 Million USD | 3.2% |
2023 FY | 231.68 Million USD | 0.29% |
2022 Q4 | 57.95 Million USD | 0.5% |
2022 Q2 | 58.7 Million USD | 3.58% |
2022 FY | 231 Million USD | 13.29% |
2022 Q1 | 56.67 Million USD | 6.06% |
2022 Q3 | 57.66 Million USD | -1.76% |
2021 Q2 | 51.76 Million USD | 5.58% |
2021 Q1 | 49.02 Million USD | 3.46% |
2021 FY | 203.91 Million USD | 12.21% |
2021 Q3 | 49.68 Million USD | -4.01% |
2021 Q4 | 53.43 Million USD | 7.55% |
2020 Q4 | 47.38 Million USD | 8.07% |
2020 FY | 181.73 Million USD | 25.78% |
2020 Q3 | 43.85 Million USD | -2.63% |
2020 Q1 | 45.17 Million USD | 8.35% |
2020 Q2 | 45.03 Million USD | -0.3% |
2019 Q4 | 41.69 Million USD | 7.71% |
2019 Q2 | 32.75 Million USD | 4.55% |
2019 FY | 144.48 Million USD | 26.81% |
2019 Q1 | 31.33 Million USD | 1.19% |
2019 Q3 | 38.7 Million USD | 18.16% |
2018 Q1 | 23.34 Million USD | -0.95% |
2018 Q4 | 30.96 Million USD | 0.52% |
2018 FY | 113.93 Million USD | 24.08% |
2018 Q3 | 30.8 Million USD | 6.84% |
2018 Q2 | 28.83 Million USD | 23.5% |
2017 Q1 | 22.42 Million USD | 6.96% |
2017 Q4 | 23.56 Million USD | 1.38% |
2017 Q3 | 23.24 Million USD | 2.9% |
2017 FY | 91.82 Million USD | 1.06% |
2017 Q2 | 22.59 Million USD | 0.75% |
2016 FY | 90.86 Million USD | 20.67% |
2016 Q3 | 24.92 Million USD | 17.03% |
2016 Q2 | 21.3 Million USD | -9.99% |
2016 Q1 | 23.66 Million USD | 23.4% |
2016 Q4 | 20.96 Million USD | -15.91% |
2015 Q3 | 19.23 Million USD | 3.52% |
2015 FY | 75.29 Million USD | 14.67% |
2015 Q4 | 19.17 Million USD | -0.31% |
2015 Q2 | 18.58 Million USD | 1.56% |
2015 Q1 | 18.29 Million USD | 5.14% |
2014 Q1 | 14.89 Million USD | 1.86% |
2014 Q2 | 28.61 Million USD | 92.07% |
2014 Q3 | 16.87 Million USD | -41.01% |
2014 Q4 | 17.4 Million USD | 3.12% |
2014 FY | 65.66 Million USD | 25.61% |
2013 Q2 | 12.63 Million USD | 4.79% |
2013 Q3 | 12.96 Million USD | 2.61% |
2013 Q4 | 14.62 Million USD | 12.83% |
2013 FY | 52.27 Million USD | 6.95% |
2013 Q1 | 12.05 Million USD | -1.79% |
2012 Q2 | 17.81 Million USD | 0.85% |
2012 FY | 48.88 Million USD | -30.18% |
2012 Q4 | 12.27 Million USD | -28.32% |
2012 Q1 | 17.66 Million USD | 0.02% |
2012 Q3 | 17.12 Million USD | -3.87% |
2011 FY | 70.01 Million USD | 3.13% |
2011 Q1 | 17.04 Million USD | -5.08% |
2011 Q2 | 17.42 Million USD | 2.18% |
2011 Q3 | 17.88 Million USD | 2.65% |
2011 Q4 | 17.66 Million USD | -1.24% |
2010 Q2 | 16.46 Million USD | 2.08% |
2010 Q1 | 16.12 Million USD | -14.22% |
2010 Q4 | 17.96 Million USD | 3.61% |
2010 Q3 | 17.33 Million USD | 5.29% |
2010 FY | 67.88 Million USD | 4.7% |
2009 Q2 | 15.41 Million USD | 2.68% |
2009 Q3 | 15.6 Million USD | 1.26% |
2009 FY | 64.83 Million USD | 11.4% |
2009 Q4 | 18.8 Million USD | 20.45% |
2009 Q1 | 15.01 Million USD | -4.72% |
2008 Q4 | 15.75 Million USD | 5.38% |
2008 FY | 58.2 Million USD | 15.8% |
2008 Q3 | 14.95 Million USD | 0.0% |
2007 FY | 50.26 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Acadia Healthcare Company, Inc. | 176.01 Million USD | -41.421% |
AirSculpt Technologies, Inc. | 118.32 Million USD | -110.375% |
Amedisys, Inc. | 834.47 Million USD | 70.171% |
American Oncology Network, Inc. | 83.97 Million USD | -196.422% |
Astrana Health, Inc. | 112.59 Million USD | -121.072% |
Aveanna Healthcare Holdings Inc. | 587.36 Million USD | 57.621% |
IMAC Holdings, Inc. | 5.02 Million USD | -4851.537% |
biote Corp. | 98.82 Million USD | -151.877% |
Cryo-Cell International, Inc. | 35.2 Million USD | -607.05% |
Cross Country Healthcare, Inc. | 337.69 Million USD | 26.289% |
COMPASS Pathways plc | 136.91 Million USD | -81.801% |
DocGo Inc. | 180.32 Million USD | -38.038% |
The Ensign Group, Inc. | 335.39 Million USD | 25.782% |
Healthcare Services Group, Inc. | 189.09 Million USD | -31.64% |
InnovAge Holding Corp. | 558.25 Million USD | 55.411% |
Assure Holdings Corp. | 15.43 Million USD | -1512.281% |
The Joint Corp. | 109.22 Million USD | -127.901% |
LifeStance Health Group, Inc. | 491.23 Million USD | 49.327% |
Mobile-health Network Solutions Class A Ordinary Shares | 18.24 Million USD | -1264.535% |
ModivCare Inc. | 586.89 Million USD | 57.587% |
NewGenIvf Group Limited | 1.63 Million USD | -15082.279% |
Novo Integrated Sciences, Inc. | 13.5 Million USD | -1743.05% |
Option Care Health, Inc. | 666.62 Million USD | 62.66% |
P3 Health Partners Inc. | 199.56 Million USD | -24.731% |
P3 Health Partners Inc. | 199.56 Million USD | -24.731% |
The Pennant Group, Inc. | 88.99 Million USD | -179.701% |
Surgery Partners, Inc. | 319.5 Million USD | 22.091% |
Syra Health Corp. Class A Common Stock | 4.29 Million USD | -5689.512% |
Talkspace, Inc. | 97.58 Million USD | -155.07% |
Talkspace, Inc. | 97.58 Million USD | -155.07% |
The Oncology Institute, Inc. | 136.59 Million USD | -82.237% |
The Oncology Institute, Inc. | 136.59 Million USD | -82.237% |